AIR

Launch

air

NDAINHALATIONGAS
Approved
Feb 2026
Lifecycle
Launch
Competitive Pressure
30/100
Clinical Trials
20

Clinical Trials (5)

NCT07212140N/ANot Yet Recruiting

Adaptation of the STAIR-NT for First Responders

Started Jun 2026
80 enrolled
PTSD - Post Traumatic Stress DisorderTBI-Traumatic Brain Injury
NCT07413926N/ANot Yet Recruiting

Mitral Valve Repair With the Chord-X System: A Long Term Evaluation

Started Jun 2026
NCT07422610Phase 1Not Yet Recruiting

Pharmacokinetics and Safety Study of Pelabresib in Patients With Advanced Malignancies and Hepatic Impairment

Started May 2026
24 enrolled
Advanced Malignancies and Hepatic Impairment
NCT07326592Phase 4Not Yet Recruiting

Phase 4, Double-blind Study Evaluating the Response on Computed Tomography (CT) Lung Density Decline Rates of Respreeza / Zemaira Weekly for 3 Years in Adults With alpha1 Antitrypsin Deficiency (AATD)

Started Apr 2026
270 enrolled
Alpha1 Antitrypsin DeficiencyAlpha1-Proteinase Inhibitor DeficiencyEmphysema
NCT05093972Phase 1Not Yet Recruiting

Ulonivirine (MK-8507) in Participants With Mild or Moderate Hepatic Impairment (MK-8507-014)

Started Apr 2026
22 enrolled
Hepatic Insufficiency
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers